GlucoLight Corporation Awarded Patent for Tissue Oximetry Measurement Technology

Published: Apr 25, 2008

BETHLEHEM, Pa.--(BUSINESS WIRE)--GlucoLight Corporation, a development stage company focused on the non-invasive, continuous measurement of blood glucose levels, today announced that it has been awarded US Patent No. 7,356,365 for the non-invasive method and apparatus of measuring tissue oximetry. The patent was assigned to the company effective April 8, 2008.

Back to news